N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide

C45H81N9O9S — CID 129028369

IUPACN-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide
SMILESCO[C@@H]1Cc2nnn(CC(C)(C)COCC(C)(C)CN(C)C)c2CCN(C(=O)CCCC(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)C1
InChIInChI=1S/C45H81N9O9S/c1-44(2,30-52(5)6)32-63-33-45(3,4)31-54-37-17-20-53(28-34(59-7)27-35(37)50-51-54)41(57)16-10-15-40(56)47-19-12-22-61-24-26-62-25-23-60-21-11-18-46-39(55)14-9-8-13-38-42-36(29-64-38)48-43(58)49-42/h34,36,38,42H,8-33H2,1-7H3,(H,46,55)(H,47,56)(H2,48,49,58)/t34-,36+,38+,42+/m1/s1
InChIKeyAQFMLBRNCAZQFU-XWQAQMIASA-N
MW924.26 g/mol
LogP2.81
Rot. Bonds32

About N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide

N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide (PubChem CID 129028369) has the molecular formula C45H81N9O9S and a molecular weight of 924.26 g/mol. Its IUPAC name is N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide.

Molecular Properties

Compound NameN-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide
PubChem CID129028369
Molecular FormulaC45H81N9O9S
Molecular Weight924.26 g/mol
Exact Mass923.59
IUPAC NameN-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide
SMILESCO[C@@H]1Cc2nnn(CC(C)(C)COCC(C)(C)CN(C)C)c2CCN(C(=O)CCCC(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)C1
InChIInChI=1S/C45H81N9O9S/c1-44(2,30-52(5)6)32-63-33-45(3,4)31-54-37-17-20-53(28-34(59-7)27-35(37)50-51-54)41(57)16-10-15-40(56)47-19-12-22-61-24-26-62-25-23-60-21-11-18-46-39(55)14-9-8-13-38-42-36(29-64-38)48-43(58)49-42/h34,36,38,42H,8-33H2,1-7H3,(H,46,55)(H,47,56)(H2,48,49,58)/t34-,36+,38+,42+/m1/s1
InChIKeyAQFMLBRNCAZQFU-XWQAQMIASA-N
XLogP2.81
TPSA199.74 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds32
Heavy Atoms64
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500924.26
LogP ≤ 52.81
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'biotin_analogue', 'substructure': 'N/A'}

Analyze N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide?
The IUPAC name of N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide (CID 129028369) is N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide.
What is the SMILES notation for N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide?
The canonical SMILES for N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide is CO[C@@H]1Cc2nnn(CC(C)(C)COCC(C)(C)CN(C)C)c2CCN(C(=O)CCCC(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)C1.
What is the InChIKey of N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide?
The InChIKey is AQFMLBRNCAZQFU-XWQAQMIASA-N. The full InChI is InChI=1S/C45H81N9O9S/c1-44(2,30-52(5)6)32-63-33-45(3,4)31-54-37-17-20-53(28-34(59-7)27-35(37)50-51-54)41(57)16-10-15-40(56)47-19-12-22-61-24-26-62-25-23-60-21-11-18-46-39(55)14-9-8-13-38-42-36(29-64-38)48-43(58)49-42/h34,36,38,42H,8-33H2,1-7H3,(H,46,55)(H,47,56)(H2,48,49,58)/t34-,36+,38+,42+/m1/s1.
What are the key properties of N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide?
N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide has a molecular weight of 924.26 g/mol, XLogP of 2.81, 32 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propyl]-5-[(8R)-3-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]-2,2-dimethylpropyl]-8-methoxy-5,7,8,9-tetrahydro-4H-triazolo[4,5-d]azocin-6-yl]-5-oxopentanamide is sourced from PubChem (CID 129028369), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).